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Evidence-based treatments for major depressive disorder are
available, yet show disappointing results in daily practice. To
improve depression outcomes, a primary care treatment model,
collaborative care, has been developed in the USA. Key elements
of collaborative care are: continuous monitoring of symptoms,
collaboration between healthcare professionals and access to a
consultant psychiatrist. Moreover, the role of a care manager is
introduced, who coordinates care, assists in the management of
major depressive disorder and monitors treatment progress.
Currently, extensive evidence supports the effectiveness of
collaborative care, and new research projects are studying the
effectiveness of collaborative care in other countries, populations
and healthcare settings.1,2 In this study, collaborative care was
evaluated in a Dutch occupational healthcare setting (trial
registration: ISRCTN78462860).3
Major depressive disorder is a prevalent condition in Dutch
occupational healthcare settings. Dutch workers with major
depressive disorder are absent eight to nine times more often
than their colleagues without major depressive disorder.4 In
The Netherlands, occupational physicians play a central role in the
guidance of workers on sick leave. However, because treatment
and sickness certification are separated in the Dutch legislation,
there is a lack of communication and collaboration between
occupational physicians and the curative sector.5 Furthermore, access
to treatment in specialised mental healthcare is often hampered by
waiting lists. Therefore, occupational physicians aim to play a more
prominent role themselves in the care of workers on sick leave with
major depressive disorder.6 In the present study, the effectiveness of
collaborative care, applied by occupational physician–care
managers, is examined for workers with depression on sick leave.
Method
In this randomised controlled trial (RCT), the effectiveness of a
collaborative care treatment for major depressive disorder was
compared with usual care. Computer-generated randomisation
took place at participant level. In both groups, participants
received sickness guidance as usual by their company’s
occupational physician, however, only participants allocated to
the intervention group also received collaborative care from an
occupational physician–care manager. The study protocol,
including a power calculation and the method of masking, is
described in greater detail elsewhere.3,7
Workers on the sick list for between 4 and 12 weeks were
screened with the depression subscale of the Patient Health
Questionnaire (PHQ-9).8 Workers who reached the cut-off score
of 10 were contacted for the administration of a diagnostic
interview. Those who met the DSM-IV9 criteria for major
depressive disorder and gave informed consent were included.
Exclusion criteria are described elsewhere.3
The collaborative care intervention consisted of the
following elements: 6–12 sessions of problem-solving treatment,
manual-guided self-help, a workplace intervention and anti-
depressant medication. The treatment was closely monitored
using the PHQ-9. A web-based tracking system supported the
occupational physician–care manager in monitoring and in adhering
to the protocol. A psychiatrist was available for consultation.3
Data were collected at 3 months after baseline by self-report
questionnaire. The primary outcome measure was response, as
measured with the PHQ-9 and defined as a reduction of at least
50% in depressive symptoms.8 The PHQ-9 as a continuous
measure is also reported.
Data were analysed with logistic and linear multilevel analyses,
using MLwiN software, version 2.15 for Windows XP. Multilevel
analyses makes it possible to take into account the hierarchy of
the data, with locations of occupational physician–care managers
constituting the upper level and participants the level below.
Depressive symptom severity at screening was included as a base-
line correction. Post hoc, the intervention effect was explored in
participants with a baseline PHQ-9 score 515, by including an
interaction term of that covariate with the intervention variable.
Results
Of 14 595 workers approached, 2955 (20.2%) filled in the
screening questionnaire, of whom 52.5% (n= 1551) screened
positive for depression (online Fig. DS1). Subsequently, 1425
workers were excluded and 126 participants were included and
randomised in the usual care group (n= 61) or collaborative care
group (n= 65). Three months after baseline, 98 participants filled
in the questionnaire. Almost two-thirds (62%) of the collaborative
care group visited the occupational physician–care manager and
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Summary
Randomised controlled trial to evaluate the effectiveness of
collaborative care in a Dutch occupational healthcare setting:
126 workers on sick leave with major depressive disorder
were randomised to usual care (n= 61) or collaborative care
(n= 65). After 3 months, collaborative care was more
effective on the primary outcome measure of treatment
response (i.e. reduction in symptoms of 550%) on the
Patient Health Questionnaire-9 (PHQ-9). However, the groups
did not differ on the PHQ-9 as a continuous outcome
measure. Implications of these results are discussed.
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started collaborative care treatment. Baseline characterisitcs of
participants are shown in online Table DS1.
A significant difference was found between collaborative care
and usual care in achieving a response: with 50% response in
the collaborative care group and 28% response in the usual care
group, more individuals in the collaborative care group had at
least a 50% reduction in symptoms. The odds ratio was 2.514
(95% CI 1.035–6.110, P= 0.04). The corresponding number
needed to treat (NNT) is 4.5.
For usual care and collaborative care, the mean baseline
PHQ-9 scores were 16.0 and 15.9 respectively (online Table
DS2). Three months later, the mean scores were 9.9 and 8.9. Both
groups did not differ significantly from each other (P= 0.460). In
post hoc analyses, a significant difference in favour of collaborative
care was found for participants with moderately severe symptoms
at baseline (P= 0.022, online Table DS3). In that subgroup,
participants in the collaborative care group had a mean
improvement from 19.2 to 8.9 (compared with a decrease from
19.4 to 12.1 in the usual care group). Healthcare utilisation by
the participants is shown in online Table DS4.
Discussion
The present study showed that collaborative care, applied in the
occupational healthcare setting, was more effective than usual care
in terms of response to treatment among individuals on sick leave
with major depressive disorder. However, for depressive symptoms
as a continuous outcome measure, no effect for collaborative care
could be found. In post hoc analyses, collaborative care was found
to be more effective than usual care among those with moderately
severe depression. However, these latter results are secondary and
need to be interpreted carefully and confirmed in future research.
Interestingly, a significant effect was found for the dichotomous
outcome measure, whereas this was not the case for the
continuous one. As previously described by Poirier et al, this
discrepancy can be explained by the variation in the PHQ-9
scores: collaborative care participants were overrepresented in
the groups with a large decrease in symptoms and with no
improvement or a slight increase in symptoms, whereas usual care
participants were in the majority in the group with a moderate
decrease of symptoms.10 Although response is an internationally
recognised outcome measure, these results can be interpreted as
modest since an effect on the continuous outcome measure is
lacking.
The innovation in this study is the new role of the occupational
physician as care manager in the treatment of major depressive
disorder. Training and close supervision were given to them,
which, together with the web-based tracking system, made it
easier for them to adopt their new role. However, a substantial
number of the participants did not visit the occupational
physician–care manager. Waiting lists, that had to be operated
for collaborative care when the inclusion of participants increased
quickly, may have contributed to this. Another limitation of this
study is the low response rate to the screening procedure, limiting
the generalisability of our findings. This may reflect that workers
on sick leave did not feel the need for a treatment for major
depressive disorder within the occupational healthcare setting.
Because of the separation of treatment and sickness certification
in Dutch legislation, workers were probably not used to the
treatment role of the occupational physician–care manager and
a lack of confidence in the occupational physician may have
inhibited them from responding.
This was the first study examining collaborative care provided
by occupational physician–care managers. Given the modest effect
of collaborative care on reducing depressive symptoms and the
suboptimal implementation of collaborative care during the study,
further implementation of collaborative care is not yet justified.
Future research needs to confirm whether collaborative care has
added value for individuals with at least moderately severe
depression (PHQ-9 515).
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